Drug class
Melanocortin-1 receptor (MC1R) agonist; synthetic alpha-melanocyte-stimulating-hormone analogue
Mechanism of action
Activates melanocortin-1 receptors on melanocytes, increasing eumelanin production and skin pigmentation. The additional eumelanin reduces penetration of light into the skin and helps reduce phototoxic reactions in erythropoietic protoporphyria.
General use cases
- Prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP) under the EMA-authorised implant indication; specialist-centre use and product-specific monitoring apply
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
